Cookson Peirce & CO Inc Acadia Pharmaceuticals Inc Transaction History

Cookson Peirce & CO Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	BUY	$17.8 - $25.65 $1.27 Million - $1.83 Million	71,163 New	71,163 $1.7 Million
Q3 2020 Nov 04, 2020	SELL	$36.42 - $57.0 $546,190 - $854,829	-14,997 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$39.26 - $52.73 $305,128 - $409,817	7,772 Added 107.57%	14,997 $0
Q1 2020 May 04, 2020	BUY	$31.65 - $46.87 $228,671 - $338,635	7,225 New	7,225 $0

286

158M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.